• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Coats’ disease: A case study of a 4-year old boy

Optometry Times JournalFebruary digital edition 2020
Volume 12
Issue 2

Early and correct diagnosis of this congenital retinal vasculopathy vital to improve visual outcomes.

Right and left posterior pole of a 4-year-old patient with suspected Coats disea

Figure 1. Right and left posterior pole of a 4-year-old patient with suspected Coats disease. Note the subfoveal nodule with associated exudative retinopathy.

Dr. Casella headshot
4-year-old patient retinal scan with suspected Coats disease

This case study highlights the importance of a comprehensive eye examination with pupil dilation early in life, regardless of the presence or absence of signs and/or symptoms of pathology.

Recently, a 4-year-old African American male presented for his first eye examination. As per the child’s mother and father, the chief complaint was that he had failed a vision screening at his pediatrician’s office for the reasons of hyperopia and astigmatism in the right eye.

Observation the child walking back to the examination room showed a normal gait and overtly good attention to his surroundings. Medical history was unremarkable, and he was taking no medications. He also had no known medication or environmental allergies. Family history was remarkable for cataracts, high blood pressure, and glaucoma.

Related: A parent's perspective on genetic testing

Exam details

Entering uncorrected distance visual acuities by means of Allen pictures were 20/400 and 20/25 for the right eye and left eye, respectively. Near visual acuity was 20/20 with both eyes open. Color vision was normal for the left eye and was unable to be tested for the right eye. There was no frank stereopsis present.

The patient was not fully cooperative for cover test assessment, but Hirschberg testing showed no overt strabismus. Pupil testing, extraocular muscle function, and visual field assessment by means of quadrant screening were all unremarkable as well.

Anterior segment examination showed clear corneas, intact irides, open angles, and quiet lids, lashes, and conjunctivae. Anterior chambers were deep and quiet. Intraocular pressure measurements by means of rebound tonometry were 9 mm Hg in the right eye and 10 mm Hg in the left eye.

Related: Offer support to patients with inherited eye diseases

Consent was obtained from the parents for dilation, and wet retinoscopy revealed +0.75 DS in the left eye and a highly variable reflex reading in the right eye ranging from +3.75 DS to +1.00 DS with a small but variable degree of with-the-rule astigmatism.

Posterior pole examination of both eyes is as shown in Figure 1. Note the raised nodular lesion underneath the fovea and the surrounding coalesced exudative retinopathy.

More by Dr. Casella: SD-OCT shows schisis advancements due to sickle cell


I informed the child’s parents that my initial diagnosis was Coats’ disease and arranged for an urgent evaluation with a retina specialist.

I also explained the guarded visual prognosis for the right eye given foveal involvement and prescribed spectacles with impact-resistant lenses to be worn full-time to protect the left eye. At the time this piece was written, I had not heard the results of the child’s consultation with the retina specialist.

More by Dr. Casella: Be leery of large optic cups when screening for pediatric glaucoma


Coats’ disease is a typically congenital retinal vasculopathy characterized by retinal telangiectasia and subsequent exudative retinopathy.1 This condition is non-hereditary and is predominantly unilateral with a predilection for males.2

More by Dr. Casella: New research highlights how data is processed to detect glaucomatous optic neuropathy

As Coats’ disease progresses, the potential for poor visual prognosis increases.1 The most severe forms of this condition result in total retinal detachment, neovascular glaucoma, and phthisis bulbi, which are visually devastating and may necessitate enucleation.3

Coats’ disease was first described in 1908 by George Coats as a unilateral vascular disease occurring in the retinas of young males.4 It can have a highly variable clinical appearance based on the severity of the disease process at presentation.

Coats’ disease (along with, among other conditions, cataract, retinoblastoma, and persistent hyperplastic primary vitreous) is one of the causes of leukocoria and/or strabismus in a child.4 This is one reason why patients with this condition may be referred for suspicion of retinoblastoma.

More by Dr. Casella: Why taking patient history never ends

As far as visual function is concerned, one finding which leads to a more negative prognosis is the presence of a subfoveal nodule.1 Unfortunately, this patient has one of these nodules (see Figure 1). The nodules seen in some presentations of Coats’ disease contain fibrotic tissue and unfortunately have a predilection for the macula.5 These subfoveal nodules can be associated with retinal–retinal anastomosis as evidenced by fluorescein angiography;1 telangiectasias and associated areas of nonperfusion can also be evidenced in this way.1

Related: Consider IOP fluctuations when diagnosing glaucoma

Treatment of Coats’ disease is difficult and centers mainly around an attempt to lessen the retina’s demand for vascular growth. As such, laser photocoagulation and anti-vascular endotheliam growth factor (VEGF) therapy have shown efficacy in the earlier disease process, and anti-VEGF therapy with vitrectomy have shown efficacy in advanced disease.6

As with any ocular disease, early and correct diagnosis coupled with timely treatment is key in the hopes of achieving a more favorable ocular and visual outcome. Therefore, Coats’ disease is one of the reasons ODs advocate for comprehensive eye examinations with pupil dilation early in life, regardless of the presence or absence of signs and/or symptoms of pathology.

More by Dr. Casella: Look at more than the optic nerve head in glaucoma patients


1. Daruich AL, Moulin AP, Tran HV, Matet A, Munier FL. SUBFOVEAL NODULE IN COATS' DISEASE: Toward an Updated Classification Predicting Visual Prognosis. Retina. 2017 Aug;37(8):1591-1598.
2. Zhao Q, Peng XY, Yang WL, Li DJ, You QS, Jonas JB. Coats' disease and retrobulbar haemodynamics. Acta Ophthalmol. 2016 Jun;94(4):397-400.
3. Shields JA, Shields CL, Honavar SG, Demirci H, Cater J. Classification and management of Coats disease: the 2000 Proctor Lecture. Am J Ophthalmol. 2001 May;131(5):572-83.
4. Balmer A, Munier F. Differential diagnosis of leukocoria and strabismus, first presenting signs of retinoblastoma. Clin Ophthalmol. 2007 Dec;1(4):431-9.
5. Chang MM, McLean IW, Merritt JC. Coats' disease: a study of 62 histologically confirmed cases. J Pediatr Ophthalmol Strabismus. 1984 Sep-Oct;21(5):163-168.
6. Yang X, Wang C, Su G. Recent advances in the diagnosis and treatment of Coats’ disease. Int Ophthalmol. 2019 Apr;39(4):957-970.


Related Videos
Lorraine Provencher, MD, presenting slides
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Melissa Tawa, OD, FAAO
Deborah Ristvedt, DO, details CIME 2024 presentation on glaucoma management
© 2024 MJH Life Sciences

All rights reserved.